Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity
Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity
复制标题
DOI:
10.1038/s41598-020-65993-z
复制
发表时间:
2020-06-30
影响因子:
4.6
通讯作者:
Mitsuya, Hiroaki
中科院分区:
文献类型:
--
作者:
Bulut, Haydar;Hattori, Shin-ichiro;Mitsuya, Hiroaki
HIV-1 protease inhibitors (Pls), such as darunavir (DRV), are the key component of antiretroviral therapy. However, HIV-1 often acquires resistance to Pls. Here, seven novel Pls were synthesized, by introducing single atom changes such as an exchange of a sulfur to an oxygen, scission of a single bond in P2'-cyclopropylaminobenzothiazole (or-oxazole), and/or P1-benzene ring with fluorine scan of mono- or bis-fluorine atoms around DRV's scaffold. X-ray structural analyses of the Pls complexed with wild-type Protease (PRWT) and highly-multi-Pl-resistance-associated PRDRVP51R revealed that the Pls better adapt to structural plasticity in PR with resistance-associated amino acid substitutions by formation of optimal sulfur bond and adaptation of cyclopropyl ring in the S2'-subsite. Furthermore, these Pls displayed increased cell permeability and extreme anti-HIV-1 potency compared to DRV. Our work provides the basis for developing novel Pls with high potency against PI-resistant HIV-1 variants with a high genetic barrier.